Trial Profile
Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2020
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ULTRA
- 24 Apr 2012 New trial record